Ending the HIV Epidemic in the US Funding

Overview

Ending the HIV epidemic means halting HIV transmission, removing barriers to prevention and treatment, and ending HIV-related stigma for all. Unprecedented medical and technological advancements have given us the opportunity to make this vision a reality. Advancements like more effective HIV treatment, pre-exposure prophylaxis (PrEP), telehealth, telePrEP, HIV self-testing, and mobile testing ensure success is possible.

Reaching EHE goals by 2030 would prevent 255,000 HIV cases and save $100 billion in direct lifetime medical costs. Since 2019, CDC and other participating agencies have awarded health departments in 57 priority areas hundreds of millions of dollars. This funding is used to expand innovative approaches to HIV prevention, diagnosis, treatment, and cluster and outbreak response.

How it's funded

Below are the proposed and approved EHE funding levels in the President's budget requests for Fiscal Years (FY) 2019-2023. Since 2020, Congressionally approved funding has been less than the amount requested by the President. Ending the US HIV epidemic will require accelerated investments to scale up EHE's core strategies and innovations across the country.

Proposed vs. approved federal funding for EHE across agencies, FY2019-FY2023

View LargerDownload

From 2019 to 2023, approved funding for EHE increased from 35 to 613 million dollars across agencies.

_{* No funding request for FY 2019, first year EHE funding was drawn from pre-existing HIV funding.}

Proposed vs. approved federal funding for CDC’s EHE activities, FY2019-FY2023

View LargerDownload

From 2019 to 2023, approved funding for CDC’s EHE activities increased from 14 to 220 million dollars.

_{* No funding request for FY 2019.}

_{** FY 2019 funding was reallocated from other sources and does not represent a congressional appropriation.}